What’s Driving Growth in the Emphysema Treatment Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the emphysema treatment market grown in recent years?
The market for treating emphysema has witnessed robust growth in the past few years. The value of the market is projected to rise from $5.15 billion in 2024 to $5.43 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.6%. Factors such as the impact of the widespread smoking issue, developments in medical treatment, pulmonary rehabilitation initiatives, the evolution of diagnostic tools, and increased knowledge and education have contributed to this growth during the historic period.
How is the emphysema treatment market size expected to evolve during the forecast period?
The market for emphysema treatment is forecasted to experience robust expansion in the coming years, reaching a size of $7.4 billion by 2029, reflecting a compound annual growth rate (CAGR) of 8.0%. This expected growth during the forecast period is driven by factors such as the aging demographic shift, tailored treatment strategies, widened therapy access, emphasis on symptom control, and integrated healthcare approaches. Key predictive trends include gene therapies exploration, enhancement of patient knowledge and autonomy, the incorporation of artificial intelligence (AI), improved treatment accessibility, and the making of long-acting drugs.
Get your emphysema treatment market report here!
https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report
Which key drivers are propelling the emphysema treatment market’s growth?
The surge in chronic obstructive pulmonary disease (COPD) instances is predicted to boost the emphysema treatment market’s expansion. Emphysema and chronic bronchitis are among the disorders that cause airflow obstruction and breathing difficulty, collectively referred to as COPD. Emphysema treatments are critical in slowing the progression of COPD due to their focus on symptom management, lung function restoration, and disease progression delay. For instance, the Australian Institute of Health and Welfare (AIHW) published reports in June 2024 that estimated about 638,000 individuals or 2.5% of Australia’s population were living with COPD in 2022. By 2023, COPD had grown to represent 3.6% of the total disease burden, accounting for 50% of the total burden associated with respiratory conditions. Moreover, in 2022, COPD caused 7,691 deaths, translating to 29.6 fatalities per 100,000 people and accounting for 4.0% of all deaths in the country. Hence, the increasing prevalence of COPD cases fuels the emphysema treatment market’s growth.
What are the market segments in the emphysema treatment industry?
The emphysema treatment market covered in this report is segmented –
1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments
2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies
3) By End-User: Clinics, Surgical Centre, Other End-Users
Subsegments:
1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs
2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics
3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers
4) By Leukotriene Modifiers: Montelukast, Zafirlukast
5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems
6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines
7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides
8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation
9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp
Which leading companies are shaping the growth of the emphysema treatment market?
Major companies operating in the emphysema treatment market include AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Halozyme Therapeutics Inc., Mariposa Health Limited, Uptake Technologies Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc., Olympus Corporation
What key trends are currently impacting the emphysema treatment market’s development?
To maintain their competitive advantage in the emphysema market, major companies are innovating and focusing on minimally invasive procedures for patients. These types of medical interventions or surgical techniques cause minimal disruption to the body’s regular structures. For example, the Zephyr Valve surgery, a minimally invasive procedure, was introduced by Adena Health System, a US-based healthcare firm, in January 2022. This provides an alternative to traditional lung volume reduction surgery for sufferers of lung hyperinflation, which is frequently an issue with emphysema and COPD. This innovative method involves the placement of tiny, one-directional Zephyr Valves in the lung’s airways through a bronchoscope. These valves help in releasing entrapped air, avoid further buildup, and enable healthier sections of the lung to expand, thus enhancing breathing.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10807
Which geographic areas are influencing the growth of the emphysema treatment market?
North America was the largest region in the emphysema treatment market in 2024. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Autoimmune Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report
Infertility Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/infertility-treatment-global-market-report
Point Of Entry Water Treatment Systems Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
